1
Results: At baseline, advanced liver fibrosis was associated with worse physical health.
2
Alcohol abuse is one of the major causes of liver fibrosis worldwide.
3
Background: Increasingly, studies demonstrate the effectiveness of acupuncture therapy against liver fibrosis.
4
In patients with NASH, liver fibrosis is the main determinant of mortality.
5
Treatment benefits are more pronounced in persons with more advanced liver fibrosis.
6
WT mice on the CDAA diet developed profound steatohepatitis and liver fibrosis.
7
Advanced liver fibrosis and portal hypertension due to chronic schistosomiasis are irreversible.
8
Mini-laparoscopy-assisted liver biopsies facilitate both histological and macroscopical evaluation of liver fibrosis.
9
Background: Noninvasive tests are increasingly being used for the assessment of liver fibrosis.
10
In summary, exploration on natural products against liver fibrosis is becoming increasingly extensive.
11
Conclusion: AF is independently associated with advanced liver fibrosis in patients with NAFLD.
12
ACE deletion genotype has been linked to heart diseases, sarcoidosis and liver fibrosis.
13
However, it may not be suitable to estimate liver fibrosis or liver necroinflammation.
14
DHA is a promising candidate for the prevention and treatment of liver fibrosis.
15
Thus, galanin is a potential endogenous factor in the inhibition of liver fibrosis.
16
STAT1 could be a new therapeutic target for treating liver fibrosis.